Skip to content
Entrada Therapeutics Inc icon

Entrada Therapeutics Inc

TRDAStocksBiotechnologyUnited StatesNasdaqUSD

Price

$5.31

Today

-4.3%

YTD

-47.7%

About

Entrada Therapeutics, Inc. is a biotechnology organisation focused on the development of treatments for severe diseases. The company operates worldwide, primarily in biotechnology and medical research. Contributing to the biotechnology sector, Entrada Therapeutics provides services in the field of protein and peptide therapies. Its therapy approach seeks to address challenging diseases, with a key focus on patients suffering from untreatable issues. The company also collaborates with partners in the industry to fuel its research. Keep an eye on the price movements of TRDA stock by adding it to your eToro watchlist.

Price chart
Closing price history for TRDA (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-1.36
P/S (TTM)48.47
P/B (TTM)0.90
Market cap$209.48M
Cap tierMicro-cap
Industry avg P/E-1.99

Profitability

Gross margin21.23%
EBIT margin-3767.07%
Net margin-4762.03%
ROE-54.09%
ROA-44.35%

Earnings & Revenue

Revenue (TTM)$4.69M
Revenue growth (1Y)-94.1%
EPS (TTM)-$3.97
Free cash flow$-134.35M
Total debt$48.54M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.53
Employees152
Next earnings5 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Entrada Therapeutics Inc (TRDA) | Dirk Kuyken